CARULLI, Lucia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.192
AS - Asia 6.649
EU - Europa 5.751
SA - Sud America 864
AF - Africa 141
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 9
Totale 28.627
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.980
SG - Singapore 2.311
CN - Cina 1.695
GB - Regno Unito 1.565
IT - Italia 1.058
HK - Hong Kong 842
BR - Brasile 655
DE - Germania 631
VN - Vietnam 619
SE - Svezia 493
FI - Finlandia 388
PL - Polonia 368
UA - Ucraina 338
FR - Francia 257
TR - Turchia 249
RU - Federazione Russa 245
BD - Bangladesh 159
KR - Corea 141
IN - India 133
BG - Bulgaria 114
CA - Canada 102
ID - Indonesia 76
IQ - Iraq 73
AR - Argentina 70
MX - Messico 58
JP - Giappone 57
PK - Pakistan 42
NL - Olanda 40
AE - Emirati Arabi Uniti 38
IE - Irlanda 38
BE - Belgio 33
ES - Italia 32
ZA - Sudafrica 31
MA - Marocco 29
AT - Austria 28
EC - Ecuador 28
VE - Venezuela 27
TW - Taiwan 26
CO - Colombia 23
MY - Malesia 22
PH - Filippine 22
CL - Cile 21
SA - Arabia Saudita 21
UZ - Uzbekistan 18
CZ - Repubblica Ceca 17
KE - Kenya 17
IR - Iran 16
AU - Australia 15
CH - Svizzera 15
CR - Costa Rica 15
PY - Paraguay 14
DZ - Algeria 12
EG - Egitto 12
ET - Etiopia 12
JO - Giordania 12
LT - Lituania 11
NO - Norvegia 10
PE - Perù 10
RO - Romania 10
AZ - Azerbaigian 9
BO - Bolivia 9
NP - Nepal 9
OM - Oman 9
TT - Trinidad e Tobago 9
AL - Albania 8
PA - Panama 8
BY - Bielorussia 6
DK - Danimarca 6
KG - Kirghizistan 6
SI - Slovenia 6
TH - Thailandia 6
TN - Tunisia 6
UY - Uruguay 6
BA - Bosnia-Erzegovina 5
EU - Europa 5
GE - Georgia 5
HU - Ungheria 5
NG - Nigeria 5
NI - Nicaragua 5
NZ - Nuova Zelanda 5
RS - Serbia 5
DO - Repubblica Dominicana 4
IL - Israele 4
JM - Giamaica 4
PS - Palestinian Territory 4
UG - Uganda 4
AM - Armenia 3
GR - Grecia 3
HR - Croazia 3
KZ - Kazakistan 3
MD - Moldavia 3
PT - Portogallo 3
SY - Repubblica araba siriana 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AO - Angola 2
BF - Burkina Faso 2
BH - Bahrain 2
GH - Ghana 2
KH - Cambogia 2
KW - Kuwait 2
Totale 28.592
Salva come PNG Salva come JPEG
Città #
Singapore 1.594
Fairfield 1.379
Ashburn 1.316
Santa Clara 1.263
Southend 978
Hong Kong 831
Woodbridge 759
Houston 732
Chandler 697
Jacksonville 551
Chicago 532
San Jose 526
Seattle 471
Wilmington 468
Cambridge 463
Dearborn 417
Ann Arbor 408
Los Angeles 384
Hefei 355
Warsaw 354
Beijing 341
Nyköping 319
London 284
Helsinki 266
Modena 230
Salt Lake City 210
Council Bluffs 190
Ho Chi Minh City 189
The Dalles 167
New York 162
San Diego 155
Hanoi 153
Izmir 134
Munich 130
Seoul 129
Princeton 122
Tampa 114
Sofia 111
Eugene 101
Shanghai 95
Milan 94
Elk Grove Village 90
Lauterbourg 88
Buffalo 78
Dallas 71
São Paulo 59
Fremont 54
Sterling 54
Moscow 52
Des Moines 48
Lancaster 48
Columbus 47
Jakarta 46
Rome 45
Guangzhou 40
Baghdad 39
Bologna 38
Frankfurt am Main 38
Redwood City 38
Orem 36
Boardman 35
Tokyo 35
Phoenix 33
Turku 33
Dublin 32
Toronto 32
Brussels 29
Detroit 28
Mexico City 28
Brooklyn 27
Dulles 27
Falls Church 26
Miami 26
Bremen 25
Montreal 25
Haiphong 24
Da Nang 23
Kunming 23
Chennai 22
San Francisco 22
San Mateo 22
Dongguan 20
Parma 20
Manchester 19
Zhengzhou 18
Amsterdam 17
Bari 17
Dhaka 17
Hounslow 17
Norwalk 17
Nuremberg 17
Tashkent 17
Atlanta 16
Denver 15
Kansas City 15
Mumbai 15
Rio de Janeiro 15
Boston 14
Kilburn 14
Nanjing 14
Totale 20.074
Salva come PNG Salva come JPEG
Nome #
ABCB4 and ABCB11 mutations in intrahepatic cholestasis of pregnancy in an Italian population 708
17 Beta-estradiol prevents cytotoxicity from hydrophobic bile acids in HepG2 and WRL-68 cell cultures 466
Increased appearance rate of 27-hydroxycholesterol in vivo in hypercholesterolemia: A possible compensatory mechanism. 450
Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes 422
Gender, fatty liver and GGT 419
Age-related changes in bile acid synthesis and hepatic nuclear receptor expression 414
Gallstone disease in non-alcoholic fatty liver: Prevalence and associated factors 409
Changes in bile acid synthesis in gallstone disease: cause, consequence or neither? 408
Decreased hepatic expression of PPAR-gamma coactivator-1 in cholesterol cholelithiasis. 405
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 398
Human Immunodeficiency Virus Is the Major Determinant of Steatosis and Hepatitis C Virus of Insulin Resistance in Virus-associated Fatty Liver Disease. 395
Review article: the metabolic syndrome and non-alcoholic fatty liver disease 377
Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study (Internal and Emergency Medicine, (2018), 13, 5, (651-660), 10.1007/s11739-018-1835-9) 376
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 375
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 369
Review article: diabetes, genetics and ethnicity 368
Suppression of bile acid synthesis, but not of hepatic cholesterol 7alpha-hydroxylase expression, by obstructive cholestasis in humans 365
APOE MODENA : A NOVEL APOE MUTANT CAUSING LIPOPROTEIN GLOMERULOPATHY 364
Genetic determinants of susceptibility and severity in nonalcoholic fatty liver disease. 360
Is nonalcoholic steatohepatitis associated with a high-though-normal thyroid stimulating hormone level and lower cholesterol levels? 350
Hepatic steatosis and insulin resistance: Does etiology make a difference? 348
Age-associated alterations in cholesterol homeostasis: evidence from a cross-sectional study in a Northern Italy population. 347
Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients 343
Correlation between plasma levels of 7alpha-hydroxy-4-cholesten-3-one and cholesterol 7alpha-hydroxylation rates in vivo in hyperlipidemic patients 341
Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: Prevalence and correlates 337
Endocrine and liver interaction: the role of endocrine pathways in NASH 334
Telomere length elongation after weight loss intervention in obese adults 332
In Vivo Degradation of Cholesterol to Bile Acids Is Reduced in Patients Receiving Parenteral Nutrition. 322
Genetic polymorphisms in non-alcoholic fatty liver disease: Interleukin-6-174G/C polymorphism is associated with non-alcoholic steatohepatitis 322
Hepatitis C virus-infected patients are 'spared' from the metabolic syndrome but not from insulin resistance. A comparative study of nonalcoholic fatty liver disease and hepatitis C virus-related steatosis 320
Bile acids and nonalcoholic fatty liver disease: An intriguing relationship 320
Classical and innovative insulin sensitizing drugs for the prevention and treatment of NAFLD 313
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 309
Nuclear receptors as potential molecular targets in cholesterol accumulation conditions: Insights from evidence on hepatic cholesterol degradation and gallstone disease in humans 309
Regulation of ob gene expression: evidence for epinephrine-induced suppression in human obesity 308
Lung fibrosis, bone marrow fibrosis and liver cirrhosis: A Short Telomere Syndrome or a casual association? 300
Synchronous cryptogenic liver cirrhosis and idiopathic pulmonary fibrosis: a clue to telomeres involvement on line pubblication 03-Oct-2012Hepatology- 299
INCREASED 27-HYDROXYLATION OF CHOLESTEROL IN PRIMARY HYPERCHOLESTEROLEMIA 291
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 287
Risk for cardiovascular events in an Italian population of patients with type 2 diabetes 282
Olanzapine metabolic side effects: a weight gain issue? 280
Hepatic nuclear receptors in human cholelithiasis: A link with insulin resistance? 279
Telomere and telomerase in chronic liver disease and hepatocarcinoma 274
Carotid plaque detection improves the predictve value of CHA2DS2-VASc score in patients with non-valvular atrial fibrilation: The ARAPACIS Study 273
Review article: effect of bile salt pool composition on hepatic and biliary functions 269
Angiopoietin-2/Tie2 Inhibition by Regorafenib Associates With Striking Response in a Patient With Aggressive Hepatocellular Carcinoma 269
Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD. 268
The Individual Care Plan (ICP): proposal of a model to improve the communication between hospital and primary health care services 265
MOLECULAR REGULATION OF STEROL METABOLISM BY BILE ACIDS IN CULTURED HUMAN HEPATOCYTES 258
Antiretroviral drugs induced metabolic diseases in HIV infected patients. 257
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 254
ESTIMATION OF CARDIOVASCULAR RISK IN TYPE 2 DIABETES 254
NAFLD AND TYPE 2 DIABETES: A GENETIC OR METABOLIC ISSUE? 250
Genetic polymorphism PC-1 K121Q and ethnic susceptibility to insulin resistance. 243
Influence of age on bile acid synthesis: Role of hepatic expression of nuclear receptors 239
Cholesterol metabolism in gallstone disease .Preliminary evidence from the analysis of circulating markers of sterol homeostasis 236
HEPATIC EXPRESSION OF NUCLEAR RECEPTORS AND BILIARY TRANSPOTERS IN HUMAN CHOLESTEROL GALLSTONE DISEASE. 233
Dynamic angiopoietin-2 assessment predicts survival and chronic course in hospitalized patients with COVID-19 233
Bleeding jejunal varices and portal thrombosis in a splenectomized patient with hereditary spherocytosis 233
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 227
HEPATIC NUCLEAR RECEPTOR EXPRESSION AND REGULATION OF BILE ACID SYNTHESIS IN HUMANS 226
Telomere shortening as genetic risk factor of liver cirrhosis 225
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 221
RISK FOR CARDIOVASCULAR EVENTS IN AN ITALIAN POPULATION OF PATIENTS WITH TYPE 2 DIABETES 217
Regolazione della sintesi di colesterolo e acidi biliari 214
Pattern of in-hospital changes in drug use in the older people from 2010 to 2016 211
Nuclear receptors and obstructive cholestasis in Humans: increased heaptic expression of short heterodimer partner : a protective response? 209
Increase degradation of cholesterol via the alternate pathway of bile acid biosynthesis in primary hypercholesterolemia. 205
Influence of newly synthesized cholesterol on bile acid synthesis during chronic inhibition of bile acid absorption 204
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 203
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 203
Gender differences in chronic alcoholic and viral liver diseases 203
Telomeres and atherosclerosis 202
TYPE 2 DIABETES AND CARDIOVASCULAR EVENTS : STUDY OF THE AMIN RISK FACTORS IN A LOCAL POPULATION OF PATIENTS 201
Cirrosi criptogenetiche. Un report di 5 pazienti 199
Fatty liver, carotid disease and gallstones: A study ofage-related associations 198
Olanzapine-induced hypertriglyceridemia and Diabetes mellitus 197
HEPATIC NUCLEAR RECEPTOR EXPRESSION AND REGULATION OF BILE ACID SYNTHESIS IN HUMANS 195
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients 195
The neck-liver axis. Madelung disease as further evidence for an impact of body fat distribution on hepatic histology 194
NAFLD AND TYPE 2 DIABETES: A GENETIC OR METABOLIC ISSUE? 193
Reply 193
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 189
Cholestatic icterus: is there still a role for the clinic? 187
The genetic basis of Insulin resistance. A brief review 186
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 181
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 178
Structure and concentartion of differenty fatty acid (FFAS) affect steatosis extent and apoptosis in hepatocytes coltures 170
Risk for cardiovascular events in a local population of diabetic patients 167
RISK FOR CARDIOVASCULAR EVENTS IN A LOCAL POPULATION OF DIABETIC PATIENTS 166
Tipologia dei ricoveri negli Ospedali Universitari: l'impatto sulle attività istituzionali 165
Epidemiologia e storia naturale dell'epatopatia steatosica non alcolica 160
Fatty liver disease associated with epatiti C and/or human immunodeficiency virus: characterization of the link between hepatic steatosis, insulin resistance and metabolic syndrome. 159
Living alone as an independent predictor of prolonged length of hospital stay and non-home discharge in older patients 159
Prognostic significance of hypoxic and metabolic gene profiling in hepatocellular carcinoma 158
regulation of bile acid synthesis in humans: availability of newly sythetized cholesterol is a limiting fator during pharmacological inhibition of bile acid recirculation. 155
La calcolosi biliare. 154
DIABETES AND CARDIOVASCULAR EVENTS: USEFULNESS AND LIMITS OF RISK FUNCTIONS 154
Does fatty liver associate with carotid atherosclerosis? 152
The OMICs window into nonalcoholic fatty liver disease (NAFLD) 145
Totale 27.149
Salva come PNG Salva come JPEG
Categoria #
all - tutte 114.526
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 114.526
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202199 0 0 0 0 0 0 0 0 0 0 0 99
2021/20222.398 108 303 160 203 64 115 182 147 282 133 421 280
2022/20231.970 220 203 170 197 211 312 42 173 248 15 78 101
2023/20241.332 55 71 86 91 253 134 209 165 26 31 65 146
2024/20254.606 120 56 87 322 944 705 304 236 431 213 489 699
2025/202610.137 470 305 606 1.317 2.613 1.022 1.086 404 837 787 583 107
Totale 28.812